STAMPEDE / LATITUDE coverage overview 2017 ASCO Annual Meeting
Artwork: Cliff Enright, Star Cradle th Artwork from The Creative Center Last updated 9 June 2017 at University Settlement EU Coverage Snapshot
2 UK
3 4 5 6 7 8 9 France: More 80 articles in 3 days… France: Broad coverage across different media
. Online general media: leparisien.fr, lepoint.fr, oues- France.fr, sciencesetavenir, Femme Actuelle, les Echos, Boursorama . National Press Agency: AFP (all regional daily papers will probably replicate the story) . Online TV and radios: France Inter, France 24, TV5 Monde, Europe 1, France Télévision . Online regional media: Paris Normandie, Ouest France, la Dépêche, le Télégramme, la Provence, le Courrier de l’Ouest, Centre presse . Online medical media: Pourquoi Docteur, K Onco, Cancer.fr, la lettre du cancérologue, Doctissimo, docteurjd . Print National Media: Le Monde, le Parisien
11 Nordics: Spread from Trade Titles to Lay Press
12 Sweden
13 Sweden
14 Sweden
15 http://www.sydostran.se/tt-inrikes/battre-prognos-for-manlig-cancer/
16 Denmark
17 Denmark
18 - Denmark continued
19 Norway
20 Norway
21 Finland
22 Finland
23 Finland
24 Finland
25 Germany
26 Germany
27 Germany
28 Netherlands/ Belgium
29 Italy
30 Italy
31 Italy
32 Coverage summary
DATE PUBLICATION LINK
02.06.17 The Pharma Letter https://www.thepharmaletter.com/article/zytiga-results-transformational-says-janssen-s-oncology-vp
http://ecancer.org/news/11710-asco-2017--latitude-trial-of-abiraterone-for-metastatic-prostate-cancer- 03.06.17 Ecancer doubles-median-pfs.php
http://www.bioportfolio.com/news/article/3168259/ASCO-2017-LATITUDE-trial-of-abiraterone-for- 03.06.17 BioPortfolio metastatic-prostate-cancer-delays-growth.html
http://www.cancernetwork.com/asco-prostate-cancer/abiraterone-adt-combo-increased-prostate-cancer- 03.06.17 Cancer Network survival
http://www.fiercepharma.com/pharma/j-j-s-zytiga-slashes-death-risk-by-38-earlier-stage-prostate-cancer- 03.06.17 Fierce Pharma patients http://clinicaltrials.pharmaceutical-business-review.com/news/jjs-prostate-cancer-drug-zytiga-shows- 05.06.17 Pharmaceutical Business Review significant-effect-in-phase-3-trial-050617-5833030
05.06.17 Scrip TBC
05.06.17 Pharmacy Choice http://www.pharmacychoice.com/news/article.cfm?Article_ID=1769027
06.06.17 serengo.net N/A
06.06.17 LE TRIBUNE N/A
33 Coverage summary
DATE PUBLICATION LINK
03.06.17 Boursorama.com N/A
N/A 03.06.17 bienpublic.com
03.06.17 portail.free.fr N/A
04.06.17 leparisien.fr N/A
04.06.17 CENTRE PRESSE AVEYRON N/A
04.06.17 femmeactuelle.fr N/A
04.06.17 pourquoidocteur.fr N/A
04.06.17 24matins.fr N/A
http://portail.free.fr/lifestyle/forme/7045638_20170603_avancee-importante-contre-le-cancer-de-la- 04.06.17 portail.free.fr prostate.html
04.06.17 businesswire.fr N/A
04.06.17 itespresso.fr N/A
04.06.17 LE TELEGRAMME N/A
04.06.17 OUEST FRANCE N/A
04.06.17 AUJOURD'HUI EN FRANCE N/A
34 Coverage summary
DATE PUBLICATION LINK
http://lecancer.fr/congres/congres-americain-cancerologie-2017-pharma/congres-americain-cancerologie-2017- 05.06.17 serengo.net pharma-4juin/lacetate-dabiraterone-permet-aux-porteurs-de-cancer-de-prostate-metastatiques-delargir- drastiquement-leurs-perspectives/ 05.06.17 news.radins.com https://news.radins.com/actualites/cancer-la-prostate-un-nouveau-traitement-prometteur,35561.html
05.06.17 femmeactuelle.fr N/A
05.06.17 francetvinfo.fr N/A
05.06.17 feminactu.com N/A
http://www.augsburger-allgemeine.de/wissenschaft/Hoehere-Lebenserwartung-bei-Prostatakrebs-neue-Therapie- 06.06.16 augsburger-allgemeine.de id41647726.html 06.06.16 http://www.t-online.de/gesundheit/krankheiten-symptome/krebs/id_81371522/franzoesische-forscher-bremsen- t-online.de prostatakrebs.html
06.06.16 Het Nieuwsbla N/A
06.06.16 The Age N/A
06.06.16 De Tijd N/A
06.06.16 Destination Sante N/A
06.06.16 Le Republican Lorrain N/A
06.06.16 eei-biotechfinances.com N/A
06.06.16 destinationsante.com N/A
06.06.16 medisite.fr N/A 06.06.16 letempsdesbanlieues.com N/A
35 Coverage summary
DATE PUBLICATION LINK
http://www.cancernetwork.com/asco-prostate-cancer/stampede-abiraterone-slowed-progression-advanced- 03.06.2017 Cancer Network prostate-cancer
https://www.urotoday.com/conference-highlights/asco-2017/asco-2017-press-releases/96169-asco-abiraterone- 03.06.2017 UroToday slows-advanced-prostate-cancer-helps-patients-live-longer.html
03.06.2017 ASCO Post http://www.ascopost.com/News/55699
Institute of Cancer http://www.icr.ac.uk/news-archive/adding-abiraterone-to-standard-treatment-improves-prostate-cancer-survival- 07.06.2017 Research by-almost-40
03.06.2017 The Guardian https://www.theguardian.com/society/2017/jun/03/prostate-cancer-therapy-study-abiraterone
http://www.independent.co.uk/news/health/hope-for-20000-prostate-cancer-patients-after-worlds-biggest- 03.06.2017 The Independent treatment-trial-a7770871.html http://ecancer.org/conference/940-2017-asco-annual-meeting/video/5973/asco-2017--following-the-practice- 04.06.2017 Ecancer changing-results-from-stampede.php
05.06.2017 Medical Xpress https://medicalxpress.com/news/2017-06-abiraterone-advanced-prostate-cancer-patients.html
03.06.17 Daily Mirror http://www.mirror.co.uk/news/uk-news/miracle-drug-combination-means-20000-10555490
http://www.express.co.uk/life-style/health/812697/Prostate-cancer-Drug-trial-breakthrough-DOUBLE-life- 04.06.17 Daily Express expectancy-treatment
03.06.17 BBC News http://www.bbc.co.uk/news/health-40131381
03.06.17 The Daily Telegraph http://www.telegraph.co.uk/news/2017/06/03/enormously-exciting-prostate-cancer-treatment-promises-hope/
03.06.17 The Daily Mail http://www.dailymail.co.uk/health/article-4570406/Breakthrough-prostate-cancer-boosts-survival-rate.html
https://www.thesun.co.uk/living/3718472/combination-of-drugs-could-cure-prostate-cancer-or-extend-the-life-of- 03.06.17 The Sun sufferers/ 03.06.2017 ICD Medicina http://www.institutodecancer.com.br/site/stampede-abiraterona-na-primeira-linha-cancer-de-prostata-avancado/
36 Coverage summary
DATE PUBLICATION LINK
03.06.17 MedScape http://www.medscape.com/viewarticle/881078
03.06.17 Prostate Cancer Foundation https://www.pcf.org/news/breaking-news-2017-asco-meeting-results-from-the-latitude-study/
http://www.targetedonc.com/conference/asco-2017/early-intervention-with-abiraterone-significantly- 03.06.17 Targeted Oncology reduces-risk-in-metastatic-prostate-cancer-results-of-2-studies-show
http://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-06-03-giving-prostate- 03.06.17 CRUK cancer-drug-earlier-extends-lives-of-men-whose-disease-has-spread
03.06.17 EP Vantage http://epvantage.com/Universal/View.aspx?type=Story&id=711970&isEPVantage=yes¬Sub=false
03.06.17 la1ere.francetvinfo.fr N/A
03.06.17 www.france24.com N/A
03.06.17 information.tv5monde.com N/A
03.06.17 www.nordnet.fr N/A
AGENCE FRANCE PRESSE 03.06.17 N/A MONDIALES
03.06.17 www.paris-normandie.fr N/A
03.06.17 www.lepoint.fr N/A
03.06.17 www.ouest-france.fr N/A
03.06.17 www.leparisien.fr N/A
03.06.17 AFP N/A
37 Coverage summary
DATE PUBLICATION LINK
03.06.2017 Dagens Medicin https://www.dagensmedicin.se/artiklar/2017/06/03/tidig-behandling-med-zytiga-gav-battre-overlevnad/
03.06.2017 Dagens Medicin https://www.dagensmedisin.no/artikler/2017/06/03/-gjennombrudd-for-behandling-av-prostatakreft/
http://diariovision.com.ar/salud/medicamento-alarga-las-vidas-de-los-pacientes-con-cancer-de-prostata- 03.06.2017 Diario Vision avanzado/
04.06.17 First Word Pharma https://www.firstwordpharma.com/node/1477011#axzz4j7KdNyln
04.06.17 Normangee Star http://normangeestar.net/2017/06/04/study-shows-early-zytiga-use-improves-prostate-cancer-survival/
Click Lancashire 04.06.17 http://clicklancashire.com/2017/06/04/j-js-zytiga-boosts-survival-in-new-severe-prostate-cancers.html Independent News http://am.asco.org/adt-plus-abiraterone-improves-survival-hormone-sensitive-advanced-prostate- 04.06.17 ASCO Daily News cancer?j=39315690&sfmc_sub=1808137054&l=18416124_HTML&u=670648835&mid=10831468&jb=53&et_ci d=39315690&et_rid=1808137054&linkid=ADT LE POPULAIRE DU 04.06.17 N/A CENTRE LE PETIT BLEU DE 04.06.17 N/A L'AGENAIS
04.06.17 portail.free.fr N/A
04.06.17 www.ladepeche.fr N/A
04.06.17 LA PROVENCE N/A
04.06.17 www.doctissimo.fr N/A
04.06.17 www.boursorama.com N/A
04.06.17 www.docteurjd.com N/A
38 Coverage summary
DATE PUBLICATION LINK
N/A 04.06.17 A DEPECHE DU MIDI
04.06.17 Quotidiano.it http://www.quotidiano.net/benessere/corpo%20e%20mente/prostata-abiraterone-1.3174256
http://www.philly.com/philly/health/topics/HealthDay723340_20170605_Drug_Extends_Lives_of_Patients_With 05.06.17 Philly.com _Advanced_Prostate_Cancer__Studies.html http://www.oncologynurseadvisor.com/asco-2017/abiraterone-addition-to-adt-improves-high-risk-prostate- 05.06.17 Oncology Nurse Adviser cancer-survival/article/666458/ http://www.pmlive.com/pharma_news/practice- 05.06.17 PM Live changing_data_for_j_and_js_zytiga_in_prostate_cancer_1194788# 05.06.17 The News Recorder http://www.thenewsrecorder.com/abiraterone-new-approach-for-treatment-of-prostate-cancer/36173
05.06.17 Pharmaphorum https://pharmaphorum.com/news/asco-data-points-zytiga/
05.06.17 Newsweek http://www.newsweek.com/alectinib-alecensa-abiraterone-zytiga-survival-lung-cancer-prostate-cancer-620930
http://www.fiercepharma.com/pharma/pfizer-s-14b-medivation-deal-s-now-a-cautionary-m-a-tale-thanks-to- asco-data- analyst?utm_medium=nl&utm_source=internal&mrkid=22311031&mkt_tok=eyJpIjoiWkdZeU1UZGlaakJrWXpOa 05.06.17 Fierce Pharma iIsInQiOiJpUjVhb1NqbDNFRUF6b01BdStkZ2xLTkswWlRYaGpWVFRiazFLeThlMTYyOVFHTDZ6ckJaOURFVVNGazJV OHhJT3d3Y2NcL0ZjU3BhT2ZjanNTYnJDNVhuZDB0anJLRkh5N3NLR3ZYUkd0d01EdEU4UHQyZjFveVwvcDI0QlRBR G5IIn0%3D 05.06.17 CBS http://www.cbsnews.com/news/drugs-fight-breast-lung-prostate-cancers-lynparza-zytiga/
http://www.renalandurologynews.com/prostate-cancer/first-line-abiraterone-adt-combo-for-hormone- 05.06.17 Renal and Urology News na%C3%AFve-prostate-cancer-ups-survival/article/666244/ 05.06.17 NewsMax Health http://www.newsmax.com/Health/Health-News/Health-US-cancer-pharma/2017/06/05/id/794136/ N/A 05.06.17 la lettre du cancérologue N/A 05.06.17 LE COURRIER DE L'OUEST https://www.aerzteblatt.de/nachrichten/76178/Abirateron-Fruehzeitiger-Einsatz-beim-fortgeschrittenen- 06.06.16 aerzteblatt.de Prostatakrebs-verlaengert-Ueberleben-in-zwei-Studien
39 Coverage summary
DATE PUBLICATION LINK
06.06.17 Ecancer Video http://ecancer.org/video/5903/asco-2017--expert-discussion-on-the-latest-in-prostate-cancer.php
http://specialty.mims.com/topic/latitude-and-stampede--abiraterone-acetate---adt-a-potential-new-standard- 06.06.17 MIMS of-care-for-prostate-cancer
06.06.17 Le Quotidien du medecin N/A
06.06.17 Notre temps N/A
06.06.17 www.sciencesetavenir.fr N/A
https://www.sciencesetavenir.fr/sante/cancer/asco-2017-cancer-grave-de-la-prostate-une-molecule-reduit-la- 06.06.2017 Sciences et Avenir mortalite_113544 http://www.heilpraxisnet.de/naturheilpraxis/l-franzoesischen-wissenschaftlern-gelang-bedeutender-durchbruch- 07.06.17 heilpraxisnet.de bei-der-behandlung-vor-prostatakrebs-therapie-20170604279552
06.06.17 Ecancer Video http://ecancer.org/video/5903/asco-2017--expert-discussion-on-the-latest-in-prostate-cancer.php
http://specialty.mims.com/topic/latitude-and-stampede--abiraterone-acetate---adt-a-potential-new-standard- 06.06.17 MIMS of-care-for-prostate-cancer
06.06.17 Le Quotidien du medecin N/A
06.06.17 Notre temps N/A
06.06.17 www.sciencesetavenir.fr N/A https://www.sciencesetavenir.fr/sante/cancer/asco-2017-cancer-grave-de-la-prostate-une-molecule-reduit-la- 06.06.2017 Sciences et Avenir mortalite_113544 http://www.heilpraxisnet.de/naturheilpraxis/l-franzoesischen-wissenschaftlern-gelang-bedeutender-durchbruch- 07.06.17 heilpraxisnet.de bei-der-behandlung-vor-prostatakrebs-therapie-20170604279552
40 Coverage summary
DATE PUBLICATION LINK
04.06.17 ADN Kronos http://www.adnkronos.com/salute/2017/06/04/tumori-svolta-nella-terapia- cancro-prostata_zLgp8ZXfHr1XZeZ50jqqDL.html
Pharmastar http://www.pharmastar.it/news/oncoemato/cancro-alla-prostata-abiraterone- pi-antiandrogeni-migliora-del-40-la-sopravvivenza-cambia-lo-standard-di-cura- asco-2017-24205
Libero Quotidiano http://www.liberoquotidiano.it/news/salute/12403807/tumore-della-prostata- metastatico-con-abiraterone-mortalita-meno-38.html
ANSA.IT http://www.ansa.it/sito/notizie/economia/business_wire/news/2017-06- 03_1031578053.html
Salute24h http://www.saluteh24.com/il_weblog_di_antonio/2017/06/tumore-alla- prostata-aumenta-la-sopravvivenza-con-abiraterone-asco17.html
Salutedomani http://www.salutedomani.com/
Quotidiano http://www.quotidiano.net/benessere/corpo%20e%20mente/prostata- abiraterone-1.3174256
Meteoweb http://www.meteoweb.eu/2017/06/tumori-dalla-chemio-al-farmaco-svolta-per- la-terapia-per-il-cancro-alla-prostata-aggressivo/912084/
La Repubblica http://www.repubblica.it/oncologia/terapie/2017/06/03/news/abiterone_tumor e_prostata-167126969/
41